MD PhD @Oslounivsykehus, rheumatologist with special interest in scleroderma, ILD, PAH, biomarkers and microbiome.
Oslo, Norwegen
Joined October 2017
- Tweets219
- Following387
- Followers619
- Likes631
Anna Hoffmann-Vold retweeted
Thanks @EuroRespSoc for an exciting #ERSCongress🫁 and the opportunity to present findings on upfront treatment in SSc-PAH from #EUSTAR👀✅. The joint lecture by the fantastic @hoffmann_vold and her incredible colleagues showed the huge interest in the field #RheumPulm 🤩 – at Vienna, Austria
Thanks to @EuroRespSoc for inviting us to talk at this fully booked postgraduate course, @ILDIPFDoc_NI @PilarRiveraOrt1 @atzouvelekis @DrPeter_George Maria Molina-Molina, George Margaritopoulps and Claudia Ravaglia
Anna Hoffmann-Vold retweeted
📽️ Prof. Anna-Maria Hoffmann-Vold gave us a review of the most recent data from the diagnosis to the management of interstitial lung disease in RMDs at #EULAR24. -> medicaldigest.org/scientific…
@eular_org @hoffmann_vold @Oslounivsykehus #Rheumatology #MedTwitter #ILD
Thank you @eular_org for an amazing and inspiring week and the invitation to talk about “What is new in ILD” and all accepted abstract presentations from our group and @EUSTAR_org. Very proud of our teams. @HavardFretheim, @CosimoBruni, @Hildejbjork, @CampochiaroCor
Thank you @ACRheum for great days in San Diego, meeting friends and colleagues, discussing and smiling. So glad we can meet onsite again🥰 @Juge_P_A @Hildejbjork @CosimoBruni @Unispital_USZ @Oslounivsykehus
#ACR23 #postersession
Comparison of Four Risk Stratification Models for Prediction of Mortality in Systemic Sclerosis-associated Pulmonary Arterial Hypertension in the EUSTAR Cohort acrconvergencetoday.org/comp…
Anna Hoffmann-Vold retweeted
My 1st in-person talks in Europe after 4 years‼️
Thursday: Pathophysiology of ILD - Lessons & implications for therapy from Single Cell profiles of the IPF Lung
Friday: Pathophysiology of ILD - converging & diverging immune pathways in fibrotic lung disease
U of Zurich & hybrid
Anna Hoffmann-Vold retweeted
´Clinical Trial Simulations in Pulmonary Fibrosis - patient focused insights adaptations’. Delighted our paper is just out in ERJ Open Research DOI: 10.1183/ 23120541.00602-2022. @TobyMMaher @IPFWarrior @sharonlee88 @flewett @hoffmann_vold @michael_kreuter @Boehringer #CurePF
Very happy to share our recent paper assessing enrichment strategies for progressive ILD in systemic sclerosis in EUSTAR published in Chest @accpchest @EUSTAR_org
sciencedirect.com/science/ar…
Today is international day for women in science. #womeninscience Very happy to be one of them👩🏻⚕️👩🏻🔬
Exciting days at #ACR22 with great scientific sessions and meeting wonderful friends again, this evening at the @TheLancetRheum reception with Anna and Heather and finally meeting lovely @DrPujaMehta1
Join the Northern Ireland and Manchester ILD conference.
Check out "Northern Ireland and Manchester Interstitial Lung Disease 2 Day Conference" eventbrite.com/e/northern-ir… @Eventbrite
Anna Hoffmann-Vold retweeted
#MOTTIRL with dear and competent @hoffmann_vold, a rheumatologist specialized in Interstitial Lung Disease in autoimmune rheumatic diseases
#iclaf2022
Lot's in common here, so nice to meet you in person, Anna
🇧🇻❤️🇧🇷
Anna Hoffmann-Vold retweeted
Last few days to join our expert speakers at #LancetSummitRheum: Registration deadline for live participation is 12 noon BST Wednesday, Sept 21, 2022. bit.ly/LSRHEUM
Very happy to share our review on recent advances in the management of ILD in systemic sclerosis with Oliver Distler, @Katerin16265046 @bruno_crestani @CO_Pulmonary_Md journals.lww.com/co-pulmonar…
Join us in September on the @TheLancetRheum Summit on sex and gender #rheumatologi with a great program
📢 Programme announced for #LancetSummitRheum: Join a global line-up of speakers for talks and round table discussions on the latest clinical and translation research on sex and gender and #rheumatology. View the programme and register at: bit.ly/LSRHEUM
